Tenosynovitis as a possible feature of immune reconstitution syndrome during highly active antiretroviral treatment (HAART)

  • C. R
  • S. J
  • P. M
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An immune reconstitution syndrome (IRS) occurs in between 10% and 25% of patients starting highly active antiretroviral treatment (HAART). A 49-year-old patient presents a tenosynovitis 6 weeks after HAART initiation. In our patient, exhaustive tests for infectious, inflammatory and drug-related causes of tenosynovitis were negative. The improvement obtained with high-dose Non-steroidal anti-inflammatory-drug (NSAID) therapy and the patient's immunovirologic profile, supported a diagnosis of tenosynovitis associated with immune reconstitution, a form of IRS that has not previously been described. This original case increase the broad spectrum of inflammatory rheumatologic disorders associated with HIV infection. © 2009 Société française de rhumatologie.

Cite

CITATION STYLE

APA

C., R., S., J., P., M., M., G., P., B., G., P., … Pialoux, G. (2009). Tenosynovitis as a possible feature of immune reconstitution syndrome during highly active antiretroviral treatment (HAART). Joint Bone Spine, 76(5), 550–552. https://doi.org/10.1016/j.jbspin.2009.01.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free